Schedule a consultation with a provider today
These may be administered through an IV or oral supplement depending on the individual and their plan of care
Methods A structured literature search was conducted by the research team with the assistance of an academic librarian, with searches of six electronic databases (PubMed, Embase [Elsevier], CINAHL Complete [Ebscohost], SportDiscus [Ebscohost], BIOSIS Citation Index, and Web of Science Core Collection [Clarivate]) for studies related to BPC-157 published through March 2025
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Heres what you need to know about B12 injections and why you must choose a qualified provider to deliver them
Conservative protocols starting at 0.25 mg daily suit first-time users and those with minor injuries
